280 related articles for article (PubMed ID: 36100483)
1. Epidemiology of Renal Cell Carcinoma: 2022 Update.
Bukavina L; Bensalah K; Bray F; Carlo M; Challacombe B; Karam JA; Kassouf W; Mitchell T; Montironi R; O'Brien T; Panebianco V; Scelo G; Shuch B; van Poppel H; Blosser CD; Psutka SP
Eur Urol; 2022 Nov; 82(5):529-542. PubMed ID: 36100483
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Renal Cell Carcinoma.
Capitanio U; Bensalah K; Bex A; Boorjian SA; Bray F; Coleman J; Gore JL; Sun M; Wood C; Russo P
Eur Urol; 2019 Jan; 75(1):74-84. PubMed ID: 30243799
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of renal cell cancer.
Cho E; Adami HO; Lindblad P
Hematol Oncol Clin North Am; 2011 Aug; 25(4):651-65. PubMed ID: 21763961
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and risk factors for kidney cancer.
Chow WH; Dong LM; Devesa SS
Nat Rev Urol; 2010 May; 7(5):245-57. PubMed ID: 20448658
[TBL] [Abstract][Full Text] [Related]
5. Contemporary epidemiology of renal cell cancer.
Chow WH; Devesa SS
Cancer J; 2008; 14(5):288-301. PubMed ID: 18836333
[TBL] [Abstract][Full Text] [Related]
6. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.
Weikert S; Ljungberg B
World J Urol; 2010 Jun; 28(3):247-52. PubMed ID: 20390283
[TBL] [Abstract][Full Text] [Related]
7. Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.
Gelfond J; Al-Bayati O; Kabra A; Iffrig K; Kaushik D; Liss MA
Urol Oncol; 2018 Jul; 36(7):340.e1-340.e6. PubMed ID: 29779672
[TBL] [Abstract][Full Text] [Related]
8. Renal cell cancer among African Americans: an epidemiologic review.
Lipworth L; Tarone RE; McLaughlin JK
BMC Cancer; 2011 Apr; 11():133. PubMed ID: 21486465
[TBL] [Abstract][Full Text] [Related]
9. Geographic variation of mutagenic exposures in kidney cancer genomes.
Senkin S; Moody S; Díaz-Gay M; Abedi-Ardekani B; Cattiaux T; Ferreiro-Iglesias A; Wang J; Fitzgerald S; Kazachkova M; Vangara R; Le AP; Bergstrom EN; Khandekar A; Otlu B; Cheema S; Latimer C; Thomas E; Atkins JR; Smith-Byrne K; Cortez Cardoso Penha R; Carreira C; Chopard P; Gaborieau V; Keski-Rahkonen P; Jones D; Teague JW; Ferlicot S; Asgari M; Sangkhathat S; Attawettayanon W; Świątkowska B; Jarmalaite S; Sabaliauskaite R; Shibata T; Fukagawa A; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Bartlett JMS; Albert M; Phouthavongsy L; Ashton-Prolla P; Botton MR; Silva Neto B; Bezerra SM; Curado MP; Zequi SC; Reis RM; Faria EF; de Menezes NS; Ferrari RS; Banks RE; Vasudev NS; Zaridze D; Mukeriya A; Shangina O; Matveev V; Foretova L; Navratilova M; Holcatova I; Hornakova A; Janout V; Purdue MP; Rothman N; Chanock SJ; Ueland PM; Johansson M; McKay J; Scelo G; Chanudet E; Humphreys L; de Carvalho AC; Perdomo S; Alexandrov LB; Stratton MR; Brennan P
Nature; 2024 May; 629(8013):910-918. PubMed ID: 38693263
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of renal cell carcinoma.
Ljungberg B; Campbell SC; Choi HY; Jacqmin D; Lee JE; Weikert S; Kiemeney LA
Eur Urol; 2011 Oct; 60(4):615-21. PubMed ID: 21741761
[TBL] [Abstract][Full Text] [Related]
12. Review of potential risk factors for kidney (renal cell) cancer.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):280-93. PubMed ID: 11769880
[TBL] [Abstract][Full Text] [Related]
13. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
[TBL] [Abstract][Full Text] [Related]
14. Global epidemiology of kidney cancer.
Cirillo L; Innocenti S; Becherucci F
Nephrol Dial Transplant; 2024 May; 39(6):920-928. PubMed ID: 38341277
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of renal cell carcinoma.
Lipworth L; Tarone RE; McLaughlin JK
J Urol; 2006 Dec; 176(6 Pt 1):2353-8. PubMed ID: 17085101
[TBL] [Abstract][Full Text] [Related]
16. Hereditary renal cancer syndromes: an update of a systematic review.
Verine J; Pluvinage A; Bousquet G; Lehmann-Che J; de Bazelaire C; Soufir N; Mongiat-Artus P
Eur Urol; 2010 Nov; 58(5):701-10. PubMed ID: 20817385
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.
Rai BP; Luis Dominguez Escrig J; Vale L; Kuusk T; Capoun O; Soukup V; Bruins HM; Yuan Y; Violette PD; Santesso N; van Rhijn BWG; Hugh Mostafid A; Imran Omar M
Eur Urol; 2022 Aug; 82(2):182-192. PubMed ID: 35393159
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of renal cell carcinoma.
Lindblad P
Scand J Surg; 2004; 93(2):88-96. PubMed ID: 15285559
[TBL] [Abstract][Full Text] [Related]
19. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007.
De P; Otterstatter MC; Semenciw R; Ellison LF; Marrett LD; Dryer D
Cancer Causes Control; 2014 Oct; 25(10):1271-81. PubMed ID: 25034462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
